Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for bone health in children with neuromuscular disease undergoing hip surgery
2009-013777-17Phase 2Terminated
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pamidronate in muscle diseases (NMD) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoints: Bone Mineral Content (BMC) at 3 months post-surgery and Bone Mineral Density (BMD) at 3 months post-surgery. Started Mar 2010; status: terminated.
02
Drugs
pamidronate
03
Conditions
muscle diseases (NMD)
Beyond the preview
Go deeper on 2009-013777-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013777-17.